Literature DB >> 34293462

Updated treatment recommendations for newly diagnosed epithelial ovarian carcinoma from the ESMO Clinical Practice Guidelines.

N Colombo1, J A Ledermann2.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 34293462     DOI： 10.1016/j.annonc.2021.07.004

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  3 in total

1.  Biomarkers expression among paired serous ovarian cancer primary lesions and their peritoneal cavity metastases in treatment-naïve patients: A single-center study.

Authors:  Ilias P Nikas; Cheol Lee; Min Ji Song; Bohyun Kim; Han Suk Ryu
Journal:  Cancer Med       Date:  2022-02-25       Impact factor: 4.711

2.  Real-World Data on Newly Diagnosed BRCA-Mutated High-Grade Epithelial Ovarian Cancers: The French National Multicenter ESME Database.

Authors:  Marta Bini; Stanislas Quesada; Pierre Meeus; Manuel Rodrigues; Eric Leblanc; Anne Floquet; Patricia Pautier; Frédéric Marchal; Magali Provansal; Loïc Campion; Sylvain Causeret; Sophie Gourgou; Isabelle Ray-Coquard; Jean-Marc Classe; Christophe Pomel; Thibault De La Motte Rouge; Emmanuel Barranger; Aude Marie Savoye; Cécile Guillemet; Laurence Gladieff; Martin Demarchi; Roman Rouzier; C Courtinard; Clémence Romeo; Florence Joly
Journal:  Cancers (Basel)       Date:  2022-08-21       Impact factor: 6.575

Review 3.  Ovarian Cancer Therapy: Homologous Recombination Deficiency as a Predictive Biomarker of Response to PARP Inhibitors.

Authors:  Rowan E Miller; Osnat Elyashiv; Karim H El-Shakankery; Jonathan A Ledermann
Journal:  Onco Targets Ther       Date:  2022-10-04       Impact factor: 4.345
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.